SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-000712
Filing Date
2021-05-18
Accepted
2021-05-18 18:00:19
Documents
1
Period of Report
2021-05-13

Document Format Files

Seq Description Document Type Size
1 vera_fm4may132021.html 4  
1 vera_fm4may132021.xml 4 9650
  Complete submission text file 0000905718-21-000712.txt   11182
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Reporting) CIK: 0001397144 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 001-40407 | Film No.: 21937602

Mailing Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650-770-0077
Vera Therapeutics, Inc. (Issuer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations